Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Bioinspired Total Syntheses of Skeletally Diverse Lycopodium Alkaloids.

Created on 24 Oct 2025

Authors

Yu-Fei Ou, Yuan Jin, Zai-Feng Yuan, Jin He, Xiao-Nian Li, Qin-Shi Zhao

Published in

Journal of the American Chemical Society. Oct 23, 2025. Epub Oct 23, 2025.

Abstract

The phlegmarine skeleton is widely recognized as a key biogenetic intermediate in Lycopodium alkaloids. On this basis, we designed a phlegmarine-derived common intermediate that enables the collective, asymmetric total syntheses of 12 Lycopodium alkaloids with five distinct carbon skeletons. This intermediate was prepared on a decagram scale using commercially available (R)-pulegone in an eight-step sequence, with a stereoselective Michael addition as a key transformation. Subsequent selective carbon-carbon bond formation of this pivotal intermediate─(C4-C10, C4-C12, C1-C14, and C4-C13)─along with a skeletal rearrangement, delivered five frameworks: the huperzimine, lycodine, lycopodine, and phlegmarine classes, which were represented by (-)-hupserrine A, (-)-β-obscurine, (-)-lycopodine, (-)-cermizine B, and the lyconadin C diastereomer, respectively. Furthermore, we developed the first asymmetric total synthesis of (-)-hupserrine A, which bears a complex [6/6/5/6/7] pentacyclic cage structure and inhibits the 5-HT3A receptor (IC50 = 10.6 μM).

PMID:
41129742
Bibliographic data and abstract were imported from PubMed on 24 Oct 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 67
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement